PhillyPharma Archive: February, 2013

Medicines Patent Pool gets help on HIV/AIDS drug from Glaxo-Pfizer-Shionogi joint venture

Comment icon 0 Comments
The Medicines Patent Pool, a public health-business collaborative formed to help beat disease in the developing world, announced a new deal... Read more

FDA sends warning letter to Philly dye company, Abbey Color, about water problems in drug products

Comment icon 0 Comments
Abbey Color, Inc., an industrial dye manufacturer in the Kensington section of Philadelphia, was sent a warning letter by the U.S. Food and... Read more

FDA does not anticipate furloughs if automatic budget cuts hit

Comment icon 0 Comments
If automatic federal budget cuts kick in Friday, patients, pharmaceutical companies — and the authorities paid to protect the first group... Read more

NJ jury awards woman $3.35 million in first J&J vaginal mesh verdict

Comment icon 0 Comments
An Atlantic City jury awarded a former nurse $3.35 million for what the woman said were years of severe and chronic pain despite 18 unsuccessful... Read more

Endo Health Solutions' new CEO is Rajiv De Silva

Comment icon 0 Comments
Endo Health Solutions, Inc., now has a new chief executive officer to go along with a new headquarters in Malvern, as the board of directors... Read more

Singapore is a pharmaceutical hub, so now it aims for outer space

Comment icon 0 Comments
Singapore is not a big country, by land area, but years ago it became a big part of the global pharmaceutical world. Now it wants to send a... Read more

High-priced drug for extreme cholesterol leaves insurers wary

Comment icon 0 Comments
The FDA's December approval of lomitapide (brand-name Juxtapid) to treat extremely high cholesterol will give patients a once-a-day capsule... Read more

$78 million golden parachute for Novartis' Daniel Vasella

Comment icon 0 Comments
Novartis will pay Chairman Daniel Vasella $78 million when he departs the Swiss drugmaker, the Wall Street Journal reported over the weekend... Read more